FDA grants IceCure clearance for expanded indications of cryoablation technology and regulatory approval of MultiSense system

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

FDA granted clearance to IceCure Medical Ltd.’s cryoablation technology that destroys benign and cancerous tumors by freezing them.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

Login